{"database": "lobbying", "table": "lobbying_activities", "rows": [[1558843, "00d22196-7dc1-40a2-a9cc-0994a8c59210", "Q2", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2014, "second_quarter", "PHA", "**see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation \nH.R. 2186 - Valid Compounding Act\nH.R. 3204  The Drug Quality and Security Act, implementation\nH.R. 2725, S. 1413 - Safety Over Sequester Act, user fee sequester relief \n\n \n***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee sequester, 21st Century Cures", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2014-07-18T10:52:56.557000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1558843"], "units": {}, "query_ms": 0.854217039886862, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}